LifeMD ROE 2011-2025 | LFMD
Current and historical return on equity (ROE) values for LifeMD (LFMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| LifeMD ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.01B | $0.00B | 466.67% |
| 2024-12-31 | $-0.02B | $0.00B | 836.36% |
| 2024-09-30 | $-0.03B | $-0.01B | 10800.00% |
| 2024-06-30 | $-0.03B | $0.00B | 1866.67% |
| 2024-03-31 | $-0.03B | $0.00B | 800.00% |
| 2023-12-31 | $-0.03B | $0.01B | 454.55% |
| 2023-09-30 | $-0.03B | $-0.01B | 377.14% |
| 2023-06-30 | $-0.03B | $-0.01B | 647.62% |
| 2023-03-31 | $-0.04B | $-0.01B | 4000.00% |
| 2022-12-31 | $-0.05B | $-0.01B | -1031.58% |
| 2022-09-30 | $-0.06B | $0.00B | -423.08% |
| 2022-06-30 | $-0.06B | $0.01B | -717.65% |
| 2022-03-31 | $-0.06B | $0.02B | -1347.37% |
| 2021-12-31 | $-0.06B | $0.03B | -12400.00% |
| 2021-09-30 | $-0.08B | $-0.02B | 1216.00% |
| 2021-06-30 | $-0.09B | $-0.01B | 1911.11% |
| 2021-03-31 | $-0.07B | $0.00B | 1920.00% |
| 2020-12-31 | $-0.06B | $0.00B | 1377.78% |
| 2020-09-30 | $-0.03B | $-0.01B | 666.67% |
| 2020-06-30 | $-0.01B | $-0.01B | 254.55% |
| 2020-03-31 | $-0.01B | $0.00B | 285.71% |
| 2019-12-31 | $0.00B | $0.00B | 533.33% |
| 2019-09-30 | $0.00B | $0.00B | 1200.00% |
| 2019-06-30 | $0.00B | $0.00B | -1200.00% |
| 2019-03-31 | $0.00B | $0.00B | -400.00% |
| 2018-12-31 | $0.00B | $0.00B | -100.00% |
| 2018-09-30 | $0.00B | $0.00B | -100.00% |
| 2018-06-30 | $0.00B | $0.00B | -100.00% |
| 2018-03-31 | $0.00B | $0.00B | 133.33% |
| 2017-12-31 | $0.00B | $0.00B | -400.00% |
| 2017-09-30 | $0.00B | $0.00B | 0.00% |
| 2017-06-30 | $0.00B | $0.00B | 400.00% |
| 2017-03-31 | $0.00B | $0.00B | 800.00% |
| 2016-12-31 | $0.00B | $0.00B | 0.00% |
| 2016-09-30 | $0.00B | $0.00B | 0.00% |
| 2016-06-30 | $0.00B | $0.00B | 0.00% |
| 2016-03-31 | $0.00B | $0.00B | 0.00% |
| 2015-12-31 | $0.00B | $0.00B | 0.00% |
| 2015-09-30 | $0.00B | $0.00B | 0.00% |
| 2015-06-30 | $0.00B | $0.00B | 0.00% |
| 2015-03-31 | $0.00B | $0.00B | 0.00% |
| 2014-12-31 | $0.00B | $0.00B | 0.00% |
| 2014-09-30 | $0.00B | $0.00B | 0.00% |
| 2014-06-30 | $0.00B | $0.00B | 0.00% |
| 2014-03-31 | $0.00B | $0.00B | 0.00% |
| 2013-12-31 | $0.00B | $0.00B | 0.00% |
| 2013-09-30 | $0.00B | $0.00B | 0.00% |
| 2013-06-30 | $0.00B | $0.00B | 0.00% |
| 2013-03-31 | $0.00B | $0.00B | 0.00% |
| 2012-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.615B | $0.212B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.179B | 27.04 |
| CVS Health (CVS) | United States | $86.198B | 10.71 |
| Elevance Health (ELV) | United States | $84.314B | 10.88 |
| Cencora (COR) | United States | $57.484B | 20.00 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.963B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.509B | 17.45 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
| Solventum (SOLV) | United States | $12.912B | 13.67 |
| CochLear (CHEOY) | Australia | $12.870B | 0.00 |
| ICON (ICLR) | Ireland | $11.851B | 11.02 |
| Revvity (RVTY) | United States | $11.644B | 20.04 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Avantor (AVTR) | United States | $9.363B | 13.60 |
| HealthEquity (HQY) | United States | $9.068B | 39.72 |
| Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
| Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
| BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
| Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
| Concentras Parent (CON) | United States | $2.652B | 15.33 |
| Organon (OGN) | United States | $2.594B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
| PACS (PACS) | United States | $1.958B | 0.00 |
| Ardent Health (ARDT) | United States | $1.904B | 8.12 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.796B | 13.63 |
| GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| CareDx (CDNA) | United States | $1.074B | 16.77 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| Embecta (EMBC) | United States | $0.542B | 3.65 |
| InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| Omada Health (OMDA) | $0.460B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| So-Young (SY) | China | $0.209B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.051B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |